Literature DB >> 17568203

Intacs for keratoconus.

Yaron S Rabinowitz1.   

Abstract

PURPOSE OF REVIEW: The use of Intacs as a therapeutic modality in contact lens intolerant patients with mild to moderate keratoconus is increasingly gaining acceptance in the ophthalmic community. RECENT
FINDINGS: During the past year we have gleaned significant new information about patients who are appropriate candidates, the location and relative placement of segment sizes and long-term safety and stability after Intacs placement. Another new and exciting development which will make this procedure safer and more commonly acceptable is the use of the femtosecond laser to create the channels to insert the Intacs, which has been described for the first time this year. This technology allows for accurate depth of inserting, improved outcomes and less complications due to superficial placement. New reports about Intacs revision surgery also allows us to retreat many patients who would otherwise have been considered surgical failures.
SUMMARY: The new advances described this past year will improve outcomes and ultimately contribute to an increase in the amount of physicians performing this procedure and the number of patients requesting it.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17568203     DOI: 10.1097/ICU.0b013e3281fc94a5

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  12 in total

Review 1.  Corneal collagen crosslinking in keratoconus and other eye disease.

Authors:  Adel Alhayek; Pei-Rong Lu
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

2.  Corneal collagen cross-linking.

Authors:  Mirko R Jankov Ii; Vesna Jovanovic; Ljubisa Nikolic; Jonathan C Lake; Georgos Kymionis; Efekan Coskunseven
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

3.  Alterations of extracellular matrix components and proteinases in human corneal buttons with INTACS for post-laser in situ keratomileusis keratectasia and keratoconus.

Authors:  Ezra Maguen; Yaron S Rabinowitz; Lee Regev; Mehrnoosh Saghizadeh; Takako Sasaki; Alexander V Ljubimov
Journal:  Cornea       Date:  2008-06       Impact factor: 2.651

4.  Management of post laser in situ keratomileusis ectasia with simultaneous topography guided photorefractive keratectomy and collagen cross-linking.

Authors:  George D Kymionis; Dimitra M Portaliou; Vasilios F Diakonis; Alexandra E Karavitaki; Sophia I Panagopoulou; Mirko R Jankov Ii; Efekan Coskunseven
Journal:  Open Ophthalmol J       Date:  2011-02-11

5.  Outcomes of Single Segment Implantation of Conventional Intacs versus Intacs SK for Keratoconus.

Authors:  Mohammad Nasser Hashemian; Mohammad Ali Zare; Mehrdad Mohammadpour; Firouzeh Rahimi; Mohammad Reza Fallah; Fereydoun Keramat Panah
Journal:  J Ophthalmic Vis Res       Date:  2014 Jul-Sep

Review 6.  Updates on Managements for Keratoconus.

Authors:  Mehrdad Mohammadpour; Zahra Heidari; Hassan Hashemi
Journal:  J Curr Ophthalmol       Date:  2017-12-06

7.  Intrastromal corneal ring segments for management of keratoconus.

Authors:  Sri Ganesh; Rohit Shetty; Sharon D'Souza; Sarika Ramachandran; Mathew Kurian
Journal:  Indian J Ophthalmol       Date:  2013-08       Impact factor: 1.848

8.  Decision making nomogram for intrastromal corneal ring segments in keratoconus.

Authors:  Rohit Shetty; Sharon D'Souza; Sarika Ramachandran; Mathew Kurian; Rudy M M A Nuijts
Journal:  Indian J Ophthalmol       Date:  2014-01       Impact factor: 1.848

9.  Mini-scleral Contact Lens for Management of Poor Visual Outcomes after Intrastromal Corneal Ring Segments Implantation in Keratoconus.

Authors:  Fatemeh Alipour; Firoozeh Rahimi; Mohammad Naser Hashemian; Zahra Ajdarkosh; Ramak Roohipoor; Masoumeh Mohebi
Journal:  J Ophthalmic Vis Res       Date:  2016 Jul-Sep

10.  Femtosecond-assisted intracorneal ring segment complications in keratoconus: from novelty to expertise.

Authors:  Amr Mounir; Gamal Radwan; Mahmoud Mohamed Farouk; Engy Mohamed Mostafa
Journal:  Clin Ophthalmol       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.